44.96 USD
↗ 0.57 (1.28%)AT CLOSE (11:59 AM EDT)
Novo-Nordisk A/S
NVONYSE • USD
44.90
↘ 0.07 (0.15%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
44.90
↘ 0.07 (0.15%)
Market: CLOSED
Open?$44.61
High?$45.18
Low?$44.47
Prev. Close?$44.39
Volume?10.8M
Avg. Volume?N/A
VWAP?$44.80
Bid / Ask
Bid?$44.77 × 200
Ask?$45.00 × 800
Spread?$0.23
Midpoint?$44.89
Valuation & Ratios
Market Cap?199.3B
Shares Out?3.4B
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
NVO is currently priced at $44.96. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of May 22, 2026.
News
Profile
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Themes
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short Interest?14.0M
Days to Cover?1.0
Avg Daily Volume17.9M
Settlement Date2026-04-30